Bank of Montreal’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Bank of Montreal’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4	Closed	–	–	4972
2020 Q1	$0	Sell	4 -4,373	-100%	-$203K	﹤0.01%	5063
2019 Q4	$205K	Buy	4,377 +1,325	+43%	+$58.6K	﹤0.01%	3154
2019 Q3	$72K	Sell	3,052 -780	-20%	-$23.1K	﹤0.01%	3462
2019 Q2	$115K	Buy	3,832 +2,627	+218%	+$60.2K	﹤0.01%	3256
2019 Q1	$27K	Sell	1,205 -190	-14%	-$4.08K	﹤0.01%	3572
2018 Q4	$26K	Buy	1,395 +93	+7%	+$1.46K	﹤0.01%	3558
2018 Q3	$24K	Buy	1,302 +6	+0.5%	+$71	﹤0.01%	3657
2018 Q2	$13K	Buy	1,296 +296	+30%	+$2.04K	﹤0.01%	3897
2018 Q1	$5K	Buy	1,000 +980	+4,900%	+$7K	﹤0.01%	3929
2017 Q4	$0	Buy	+20	New	+$246	﹤0.01%	4422
2017 Q1	–	Sell	-23	Closed	–	–	4289
2016 Q4	$0	Buy	+23	New	+$313	﹤0.01%	4263

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Bank of Montreal's RARX Position: Q2 2020 in Review

Bank of Montreal sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 4 shares.

Bank of Montreal first reported a position in RARX in Q4 2016 and held it in 11 quarters. The position peaked at $205K in Q4 2019. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Bank of Montreal reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Bank of Montreal sold 4 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020.
Bank of Montreal first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2016 and held it in 11 quarters.
Bank of Montreal's Ra Pharmaceuticals, Inc. Common Stock position peaked at $205K in Q4 2019.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Bank of Montreal's 13F filing for Q2 2020, filed 12 Aug 2020.